Cargando…

Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration

BACKGROUND: Fluralaner is a novel systemic ectoparasiticide for dogs providing long-acting flea- and tick-control after a single oral dose. This study investigated the safety of oral administration of fluralaner at 3 times the highest expected clinical dose to Multi Drug Resistance Protein 1 (MDR1(-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walther, Feli M, Paul, Allan J, Allan, Mark J, Roepke, Rainer KA, Nuernberger, Martin C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975640/ https://www.ncbi.nlm.nih.gov/pubmed/24602342 http://dx.doi.org/10.1186/1756-3305-7-86

Ejemplares similares

Safety of fluralaner chewable tablets (Bravecto(TM)), a novel systemic antiparasitic drug, in dogs after oral administration
por: Walther, Feli M, et al.
Publicado: (2014)

The effect of food on the pharmacokinetics of oral fluralaner in dogs
por: Walther, Feli M, et al.
Publicado: (2014)

Safety of concurrent treatment of dogs with fluralaner (Bravecto™) and milbemycin oxime - praziquantel
por: Walther, Feli M, et al.
Publicado: (2014)

Safety of the concurrent treatment of dogs with Bravecto™ (fluralaner) and Scalibor™ protectorband (deltamethrin)
por: Walther, Feli M, et al.
Publicado: (2014)

Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs
por: Walther, Feli M., et al.
Publicado: (2015)

Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration
por: Kilp, Susanne, et al.
Publicado: (2014)

Safety of concurrent treatment of cats with fluralaner and emodepsid–praziquantel
por: Walther, Feli M., et al.
Publicado: (2016)

Erratum to: Safety of concurrent treatment of cats with fluralaner and emodepsid-praziquantel
por: Walther, Feli M., et al.
Publicado: (2016)

Safety of topical administration of fluralaner plus moxidectin concurrently with praziquantel in cats
por: Walther, Feli M., et al.
Publicado: (2018)

Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration
por: Kilp, Susanne, et al.
Publicado: (2016)

Safety of fluralaner oral solution, a novel systemic antiparasitic treatment for chickens, in laying hens after oral administration via drinking water
por: Prohaczik, Angella, et al.
Publicado: (2017)

Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™)
por: Taenzler, Janina, et al.
Publicado: (2015)

Tolerance and Pharmacokinetics of Galliprant™ Administered Orally to Collies Homozygous for MDR1‐1Δ
por: Heit, Mark C., et al.
Publicado: (2021)

Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1‐deficient collie dogs
por: Drag, Marlene, et al.
Publicado: (2022)

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs
por: Rohdich, Nadja, et al.
Publicado: (2014)

Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs
por: Taenzler, Janina, et al.
Publicado: (2014)

Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs after topical administration of fluralaner spot-on solution
por: Taenzler, Janina, et al.
Publicado: (2016)

The speed of kill of fluralaner (Bravecto™) against Ixodes ricinus ticks on dogs
por: Wengenmayer, Christina, et al.
Publicado: (2014)

A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto(TM)) treated vs. untreated dogs using the parameters tick weight and coxal index
por: Williams, Heike, et al.
Publicado: (2015)

Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats
por: Taenzler, Janina, et al.
Publicado: (2017)

Efficacy of orally and topically administered fluralaner (Bravecto(®)) for treatment of client-owned dogs with sarcoptic mange under field conditions
por: Chiummo, Rafael, et al.
Publicado: (2020)

Fluralaner activity against life stages of ticks using Rhipicephalus sanguineus and Ornithodoros moubata IN in vitro contact and feeding assays
por: Williams, Heike, et al.
Publicado: (2015)

Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs
por: Taenzler, Janina, et al.
Publicado: (2016)

Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats
por: Taenzler, Janina, et al.
Publicado: (2018)

The effect of water and shampooing on the efficacy of fluralaner spot-on solution against Ixodes ricinus and Ctenocephalides felis infestations in dogs
por: Taenzler, Janina, et al.
Publicado: (2016)

Efficacy of fluralaner spot-on solution against induced infestations with Rhipicephalus sanguineus on dogs
por: Taenzler, Janina, et al.
Publicado: (2016)

A European field assessment of the efficacy of fluralaner (Bravecto(®)) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
por: Petersen, Ivo, et al.
Publicado: (2020)

Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats
por: Rohdich, Nadja, et al.
Publicado: (2018)

Nanoparticles for antiparasitic drug delivery
por: Sun, Yuzhu, et al.
Publicado: (2019)

Antifungal and Antiparasitic Drug Delivery
por: Torrado, Juan José, et al.
Publicado: (2020)

Cytomorphology of fibromatosis colli
por: Rajalakshmi, V, et al.
Publicado: (2009)

Dr. Collie Again
por: Sussex,
Publicado: (1891)

Maurice H. Collis
Publicado: (1869)

The Current Directions of Searching for Antiparasitic Drugs
por: Dziduch, Katarzyna, et al.
Publicado: (2022)

Repositioning of Antiparasitic Drugs for Tumor Treatment
por: Li, Yan-Qi, et al.
Publicado: (2021)

Elongatio Colli Supra Vaginalis
por: Adams, Calvin Thayer
Publicado: (1888)

Reply to Collis et al.
por: Rauseo, Adriana M, et al.
Publicado: (2023)

Fibromatosis Colli: A Case Report
por: Aljahdali, Nouf F, et al.
Publicado: (2023)

Efficacy of Bravecto(®) Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) for the prevention of aelurostrongylosis in experimentally infected cats
por: Raue, Katharina, et al.
Publicado: (2021)

Progress in Redirecting Antiparasitic Drugs for Cancer Treatment
por: Huang, Haoyang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_stnj0hrg39mqqjalugb6c6mob2